News | Page 55 | Englander Institute for Precision Medicine

A three-dimensional image of a cancer cell's nucleus obtained by Dr. Faltas and his team shows the APOBEC3G protein (green) inside the nucleus (blue).

Enzyme That Protects Against Viruses Could Fuel Cancer Evolution

December 28, 2022

An enzyme that defends human cells against viruses can help drive cancer evolution towards greater malignancy by causing myriad mutations in cancer cells, according to a study led by investigators at Weill Cornell Medicine. The finding suggests that the enzyme may be a potential target for future cancer treatments.

In the new ...

A Conversation with Grad Student Matt Wickersham

December 20, 2022

We are pleased to bring you this Conversation with Matt Wickersham, a graduate student who has worked in the lab of our Director Olivier Elemento, Ph.D., and who established the Weill Cornell Medicine Wellness Qlinic, the first student-run clinic focused on addressing the mental health disparities faced by the lesbian, gay, bisexual, transgender, and queer (LGBTQ+) communities in New...

Examples of embryos evaluated by the STORK-A algorithm. From left to right, an embryo predicted to have a normal chromosome count or a single chromosomal abnormality; an embryo predicted to have a normal chromosome count; an embryo predicted to have more than one chromosomal abnormality.

Harnessing Artificial Intelligence Technology for IVF Embryo Selection

December 19, 2022

An artificial intelligence algorithm can determine non-invasively, with about 70 percent accuracy, if an in vitro fertilized embryo has a normal or abnormal number of chromosomes, according to a new study from researchers at Weill Cornell Medicine.

Having an abnormal number of chromosomes, a condition called aneuploidy, is a major reason embryos derived from in vitro fertilization (IVF) fail to implant or result in a healthy pregnancy. One of the current methods for detecting...